Wed, Mar 4, 2015, 3:01 PM EST - U.S. Markets close in 59 mins.


% | $
Quotes you view appear here for quick access.

Corixa Corporation (CRXA) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • toolatetrade toolatetrade Dec 6, 2002 3:55 PM Flag


    i don't think the fda would put bexxar back on active review status if the addional data was not
    convining. they would have held crxa on hold statas or denied the application.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • crxa was going to panel against the wishes of the FDA regardless of the change to active status of the application. The change to active status is a "non event", the panel had been set weeks before the change. Likely nothing more than horse trading prior to the inevitable panel. Keep in mind there is no new data, no new trial, just more interpretation of an outdated trial design from the mid 90's that was completed in 98/99. If you read the "Guidelines for dispute resolution above the division level" it states clearly that no additional data can be provided. The drug has activity, it is just not clear that they adequately demonstrated the risk/benefit. keep in mind c225 from imclone had activity. MAXM's maxamine was sent to panel for a public execution, don't over interpret an FDA panel being scheduled.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.